For: | Di Franco G, Usai A, Funel N, Palmeri M, Montesanti IER, Bianchini M, Gianardi D, Furbetta N, Guadagni S, Vasile E, Falcone A, Pollina LE, Raffa V, Morelli L. Use of zebrafish embryos as avatar of patients with pancreatic cancer: A new xenotransplantation model towards personalized medicine. World J Gastroenterol 2020; 26(21): 2792-2809 [PMID: 32550755 DOI: 10.3748/wjg.v26.i21.2792] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v26/i21/2792.htm |
Number | Citing Articles |
1 |
Ruo-Yue Fan, Jia-Qi Wu, Yu-Yang Liu, Xiang-Yu Liu, Si-Tong Qian, Chong-Yong Li, Ping Wei, Zhe Song, Ming-Fang He. Zebrafish xenograft model for studying mechanism and treatment of non-small cell lung cancer brain metastasis. Journal of Experimental & Clinical Cancer Research 2021; 40(1) doi: 10.1186/s13046-021-02173-5
|
2 |
Delaram Shakiba, Guy M. Genin, Silviya P. Zustiak. Mechanobiology of cancer cell responsiveness to chemotherapy and immunotherapy: Mechanistic insights and biomaterial platforms. Advanced Drug Delivery Reviews 2023; 196: 114771 doi: 10.1016/j.addr.2023.114771
|
3 |
Weijing Wang, Yongshu Li, Kaida Lin, Xiaokang Wang, Yanyang Tu, Zhenjian Zhuo. Progress in building clinically relevant patient‐derived tumor xenograft models for cancer research. Animal Models and Experimental Medicine 2023; 6(5): 381 doi: 10.1002/ame2.12349
|
4 |
Sara Bozzer, Luca De Maso, Maria Cristina Grimaldi, Sara Capolla, Michele Dal Bo, Giuseppe Toffoli, Paolo Macor. Zebrafish: A Useful Animal Model for the Characterization of Drug-Loaded Polymeric NPs. Biomedicines 2022; 10(9): 2252 doi: 10.3390/biomedicines10092252
|
5 |
Alice Usai, Gregorio Di Franco, Margherita Piccardi, Perla Cateni, Luca Emanuele Pollina, Caterina Vivaldi, Enrico Vasile, Niccola Funel, Matteo Palmeri, Luciana Dente, Alfredo Falcone, Dimitri Giunchi, Alessandro Massolo, Vittoria Raffa, Luca Morelli. Zebrafish Patient-Derived Xenografts Identify Chemo-Response in Pancreatic Ductal Adenocarcinoma Patients. Cancers 2021; 13(16): 4131 doi: 10.3390/cancers13164131
|
6 |
Jakob Siebert, Michaela Schneider, Daniela Reuter‐Schmitt, Julia Würtemberger, Annette Neubüser, Wolfgang Driever, Simone Hettmer, Friedrich G. Kapp. Rhabdomyosarcoma xenotransplants in zebrafish embryos. Pediatric Blood & Cancer 2023; 70(1) doi: 10.1002/pbc.30053
|
7 |
Bruna Costa, Marta F. Estrada, Mariana Tavares Barroso, Rita Fior. Zebrafish Patient‐Derived Avatars from Digestive Cancers for Anti‐cancer Therapy Screening. Current Protocols 2022; 2(4) doi: 10.1002/cpz1.415
|
8 |
Sara Bozzer, Michele Dal Bo, Giuseppe Toffoli, Paolo Macor, Sara Capolla. Nanoparticles-Based Oligonucleotides Delivery in Cancer: Role of Zebrafish as Animal Model. Pharmaceutics 2021; 13(8): 1106 doi: 10.3390/pharmaceutics13081106
|
9 |
Debora Corsinovi, Alice Usai, Miriam De Sarlo, Martina Giannaccini, Michela Ori. Zebrafish Avatar to Develop Precision Breast Cancer Therapies. Anti-Cancer Agents in Medicinal Chemistry 2022; 22(4): 748 doi: 10.2174/1871520621666210402111634
|
10 |
N. A. Lunina, D. R. Safina, S. V. Kostrov. Zebrafish Xenographs in Oncology and Personalized Medicine. Molecular Biology 2024; 58(3): 381 doi: 10.1134/S0026893324700031
|
11 |
Teng Wang, Jun Zou, Qiong Wu, Rui Wang, Chan-Ling Yuan, Jing Shu, Bing-Bing Zhai, Xiao-Ting Huang, Ning-Zhi Liu, Feng-Yang Hua, Xi-Cheng Wang, Wen-Jie Mei. Tanshinone IIA derivatives induced S-phase arrest through stabilizing c-myc G-quadruplex DNA to regulate ROS-mediated PI3K/Akt/mTOR pathway. European Journal of Pharmacology 2021; 912: 174586 doi: 10.1016/j.ejphar.2021.174586
|
12 |
Veronica Giusti, Giacomo Miserocchi, Giulia Sbanchi, Micaela Pannella, Claudia Maria Hattinger, Marilena Cesari, Leonardo Fantoni, Ania Naila Guerrieri, Chiara Bellotti, Alessandro De Vita, Chiara Spadazzi, Davide Maria Donati, Monica Torsello, Enrico Lucarelli, Toni Ibrahim, Laura Mercatali. Xenografting Human Musculoskeletal Sarcomas in Mice, Chick Embryo, and Zebrafish: How to Boost Translational Research. Biomedicines 2024; 12(8): 1921 doi: 10.3390/biomedicines12081921
|
13 |
Charlotte Gatzweiler, Johannes Ridinger, Sonja Herter, Xenia F. Gerloff, Dina ElHarouni, Yannick Berker, Roland Imle, Lukas Schmitt, Sina Kreth, Sabine Stainczyk, Simay Ayhan, Sara Najafi, Damir Krunic, Karen Frese, Benjamin Meder, David Reuss, Petra Fiesel, Kathrin Schramm, Mirjam Blattner-Johnson, David T. W. Jones, Ana Banito, Frank Westermann, Sina Oppermann, Till Milde, Heike Peterziel, Olaf Witt, Ina Oehme. Functional Therapeutic Target Validation Using Pediatric Zebrafish Xenograft Models. Cancers 2022; 14(3): 849 doi: 10.3390/cancers14030849
|
14 |
Yang Song, Siyuan Liu, Xin Jiang, Qingyu Ren, Hongyu Deng, Yam Nath Paudel, Baokun Wang, Kechun Liu, Meng Jin. Benzoresorcinol induces developmental neurotoxicity and injures exploratory, learning and memorizing abilities in zebrafish. Science of The Total Environment 2022; 834: 155268 doi: 10.1016/j.scitotenv.2022.155268
|
15 |
Weizheng Wu, Kunming Wen, Yuxin Zhong. Research progress in the establishment of pancreatic cancer models and preclinical applications. Cancer Innovation 2022; 1(3): 207 doi: 10.1002/cai2.31
|
16 |
Lizhen Wang, Lei Mou, Shibing Guan, Chuansen Wang, Attila Sik, Rostyslav Stoika, Kechun Liu, Meng Jin. Isoliquiritigenin induces neurodevelopmental-toxicity and anxiety-like behavior in zebrafish larvae. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 2023; 266: 109555 doi: 10.1016/j.cbpc.2023.109555
|
17 |
Gregorio Di Franco, Alice Usai, Margherita Piccardi, Perla Cateni, Matteo Palmeri, Luca Emanuele Pollina, Raffaele Gaeta, Federica Marmorino, Chiara Cremolini, Luciana Dente, Alessandro Massolo, Vittoria Raffa, Luca Morelli. Zebrafish Patient-Derived Xenograft Model to Predict Treatment Outcomes of Colorectal Cancer Patients. Biomedicines 2022; 10(7): 1474 doi: 10.3390/biomedicines10071474
|
18 |
Qian Wang, Wenxian Wang, Weiwei Pan, Xiaojing Lv, Lei Zhang, Kaiming Zheng, Fang Tian, Chunwei Xu. Case Report: Two Patients With EGFR Exon 20 Insertion Mutanted Non-Small Cell Lung Cancer Precision Treatment Using Patient-Derived Xenografts in Zebrafish Embryos. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.884798
|
19 |
Seniye Targen, Ozlen Konu. Zebrafish Xenotransplantation Models for Studying Gene Function and Drug Treatment in Hepatocellular Carcinoma. Journal of Gastrointestinal Cancer 2021; 52(4): 1248 doi: 10.1007/s12029-021-00782-z
|
20 |
Majd A. Al-Hamaly, Logan T. Turner, Angelica Rivera-Martinez, Analiz Rodriguez, Jessica S. Blackburn. Zebrafish Cancer Avatars: A Translational Platform for Analyzing Tumor Heterogeneity and Predicting Patient Outcomes. International Journal of Molecular Sciences 2023; 24(3): 2288 doi: 10.3390/ijms24032288
|
21 |
Mariana Tavares Barroso, Bruna Costa, Cátia Rebelo de Almeida, Mireia Castillo Martin, Nuno Couto, Tânia Carvalho, Rita Fior. Establishment of Pancreatobiliary Cancer Zebrafish Avatars for Chemotherapy Screening. Cells 2021; 10(8): 2077 doi: 10.3390/cells10082077
|
22 |
Gabriel Lindahl, Sebastian Fjellander, Karthik Selvaraj, Malin Vildeval, Zaheer Ali, Rusul Almter, Anna Erkstam, Gabriela Vazquez Rodriguez, Annelie Abrahamsson, Åsa Rydmark Kersley, Anna Fahlgren, Preben Kjølhede, Stig Linder, Charlotta Dabrosin, Lasse Jensen. Zebrafish tumour xenograft models: a prognostic approach to epithelial ovarian cancer. npj Precision Oncology 2024; 8(1) doi: 10.1038/s41698-024-00550-9
|
23 |
Pietro Cacialli. Expression of Nerve Growth Factor and Its Receptor TrkA in the Reproductive System of Adult Zebrafish. Veterinary Sciences 2022; 9(5): 225 doi: 10.3390/vetsci9050225
|
24 |
Lotta Mäkinen, Markus Vähä-Koskela, Matilda Juusola, Harri Mustonen, Krister Wennerberg, Jaana Hagström, Pauli Puolakkainen, Hanna Seppänen. Pancreatic Cancer Organoids in the Field of Precision Medicine: A Review of Literature and Experience on Drug Sensitivity Testing with Multiple Readouts and Synergy Scoring. Cancers 2022; 14(3): 525 doi: 10.3390/cancers14030525
|
25 |
María Cascallar, Sandra Alijas, Alba Pensado-López, Abi Vázquez-Ríos, Laura Sánchez, Roberto Piñeiro, María de la Fuente. What Zebrafish and Nanotechnology Can Offer for Cancer Treatments in the Age of Personalized Medicine. Cancers 2022; 14(9): 2238 doi: 10.3390/cancers14092238
|